New eukaryotic translation initiation factor 2B activators patented by Denali Therapeutics Oct. 16, 2019
Kappa-opioid receptor antagonists presented by the University of Kansas, University of Florida Oct. 16, 2019
Topline results reported from phase II study of REL-1017 in treatment-resistant depression Oct. 16, 2019
Collaborative Medicinal Development enrolls first patient in new study of CuATSM for ALS Oct. 15, 2019
RSS